Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,502 | 232 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $751.47 | 61 | $0 (2024) |
| Lilly USA, LLC | $308.34 | 24 | $0 (2023) |
| ABBVIE INC. | $274.44 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $259.70 | 16 | $0 (2023) |
| PFIZER INC. | $190.17 | 14 | $0 (2021) |
| Amarin Pharma Inc. | $188.77 | 11 | $0 (2021) |
| GlaxoSmithKline, LLC. | $157.60 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $154.20 | 5 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $137.53 | 8 | $0 (2021) |
| Amgen Inc. | $101.54 | 8 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $413.30 | 21 | Novo Nordisk Inc ($105.55) |
| 2023 | $229.87 | 13 | Novo Nordisk Inc ($53.24) |
| 2022 | $513.17 | 33 | ABBVIE INC. ($144.77) |
| 2021 | $774.59 | 52 | Merck Sharp & Dohme Corporation ($131.58) |
| 2020 | $128.15 | 10 | Lilly USA, LLC ($37.43) |
| 2019 | $471.57 | 37 | Novo Nordisk Inc ($109.96) |
| 2018 | $365.08 | 28 | Novo Nordisk Inc ($137.31) |
| 2017 | $606.59 | 38 | Novo Nordisk Inc ($159.26) |
All Payment Transactions
232 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.38 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: UROLOGY | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.63 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: EndoVenous Therapies | ||||||
| 07/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Cardio-renal | ||||||
| 07/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Diabetes | ||||||
| 07/08/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Endocrinology | ||||||
| 06/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Cardio-renal | ||||||
| 04/24/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: NEUROLOGY | ||||||
| 04/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Diabetes | ||||||
| 03/20/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: NEUROLOGY | ||||||
| 03/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Diabetes | ||||||
| 01/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Diabetes | ||||||
| 12/12/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/13/2023 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 08/21/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 703 | 1,407 | $73,442 | $46,514 |
| 2022 | 23 | 893 | 1,619 | $86,390 | $54,517 |
| 2021 | 25 | 1,104 | 1,880 | $105,188 | $67,088 |
| 2020 | 30 | 1,290 | 2,250 | $125,312 | $74,811 |
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 187 | $20,570 | $14,852 | 72.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 128 | 331 | $23,832 | $14,726 | 61.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 50 | 50 | $3,300 | $3,169 | 96.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 18 | 55 | $4,235 | $3,007 | 71.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 15 | 15 | $3,000 | $1,826 | 60.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 54 | 55 | $1,650 | $1,539 | 93.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 15 | $2,175 | $1,359 | 62.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 59 | 145 | $2,900 | $1,343 | 46.3% |
| 71100 | X-ray of ribs on side of body, 2 views | Office | 2023 | 28 | 29 | $1,972 | $731.43 | 37.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 14 | 14 | $1,232 | $692.45 | 56.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 16 | 17 | $1,360 | $662.66 | 48.7% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 58 | 172 | $1,720 | $650.65 | 37.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 16 | $928.00 | $605.06 | 65.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 11 | 17 | $1,122 | $498.60 | 44.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 40 | 45 | $225.00 | $220.50 | 98.0% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 31 | 57 | $513.00 | $208.82 | 40.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 23 | 24 | $192.00 | $116.66 | 60.8% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 19 | 20 | $140.00 | $116.09 | 82.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $660.00 | $96.57 | 14.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 23 | 132 | $1,716 | $93.75 | 5.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 196 | $21,560 | $14,600 | 67.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 128 | 301 | $21,686 | $14,132 | 65.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 60 | 60 | $3,960 | $3,881 | 98.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 18 | 55 | $4,235 | $3,072 | 72.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 21 | 21 | $4,200 | $2,635 | 62.7% |
About Dr. Gerald Sparks, MD
Dr. Gerald Sparks, MD is a Emergency Medicine healthcare provider based in Bay Minette, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770533507.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerald Sparks, MD has received a total of $3,502 in payments from pharmaceutical and medical device companies, with $413.30 received in 2024. These payments were reported across 232 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($3,502).
As a Medicare-enrolled provider, Sparks has provided services to 3,990 Medicare beneficiaries, totaling 7,156 services with total Medicare billing of $242,930. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Family Medicine
- Location Bay Minette, AL
- Active Since 05/11/2006
- Last Updated 02/02/2011
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1770533507
Products in Payments
- Ozempic (Drug) $313.09
- Victoza (Drug) $247.31
- Vascepa (Drug) $188.77
- BELSOMRA (Drug) $176.17
- XARELTO (Drug) $137.53
- EMGALITY (Drug) $121.00
- QULIPTA (Drug) $118.87
- XIFAXAN (Drug) $91.54
- Rybelsus (Drug) $89.98
- MYRBETRIQ (Drug) $85.52
- Kerendia (Drug) $85.39
- VRAYLAR (Drug) $83.27
- BREO (Drug) $77.04
- NUEDEXTA (Drug) $71.76
- ELIQUIS (Drug) $70.44
- ENTRESTO (Drug) $68.15
- JANUVIA (Drug) $59.54
- Tresiba (Drug) $54.15
- TRULICITY (Drug) $50.99
- Aimovig (Biological) $47.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Bay Minette
Mohammad Uddin, Md, MD
Emergency Medicine — Payments: $4,064
Dr. William Harris, Md, MD
Emergency Medicine — Payments: $615.65
Dr. Mary Sullivan, D.o, D.O
Emergency Medicine — Payments: $28.17
Dr. Aaron Schuller, M.d, M.D
Emergency Medicine